Cargando…

Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma

Progestin resistance is a problem for patients with endometrial carcinoma (EC) who require conservative treatment with progestin, and its underlying mechanisms remain unclear. YAP and TAZ (YAP/TAZ), downstream transcription coactivators of Hippo pathway, promote viability, metastasis and also drug r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Lina, Ma, Xiaohong, Hou, Yixin, Zhao, Tianyi, Sun, Rui, Qiu, Chunping, Liu, Yao, Qiu, Ziyi, Liu, Zhiming, Jiang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873621/ https://www.ncbi.nlm.nih.gov/pubmed/36693834 http://dx.doi.org/10.1038/s41420-023-01319-y

Ejemplares similares

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

Verteporfin-induced proteotoxicity impairs cell homeostasis and survival in neuroblastoma subtypes independent of YAP/TAZ expression
por: Condurat, Alexandra-Larisa, et al.
Publicado: (2023)

Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma
por: Ma, Xiaohong, et al.
Publicado: (2021)

Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells
por: Dasari, Venkata Ramesh, et al.
Publicado: (2017)

Docking analysis of verteporfin with YAP WW domain
por: Kandoussi, Ilham, et al.
Publicado: (2017)

DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma
por: Zhou, Qing, et al.
Publicado: (2019)

PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy
por: Liu, Hua, et al.
Publicado: (2017)

Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein Survivin in a light-independent manner
por: Hasegawa, Takashi, et al.
Publicado: (2021)

ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL
por: Ma, Xiaohong, et al.
Publicado: (2022)

Multifaceted regulation and functions of YAP/TAZ in tumors
por: Liu, Huirong, et al.
Publicado: (2018)

DNA binding partners of YAP/TAZ
por: Kim, Min-Kyu, et al.
Publicado: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

YAP and TAZ regulate cell volume
por: Perez-Gonzalez, Nicolas A., et al.
Publicado: (2019)

Mechanisms of YAP/TAZ transcriptional control
por: Battilana, Giusy, et al.
Publicado: (2021)

YAP/TAZ in Bone and Cartilage Biology
por: Zarka, Mylène, et al.
Publicado: (2022)

YAP/TAZ dull the STING of aging
por: Francisco, Jamie, et al.
Publicado: (2022)

Nuclear Import and Export of YAP and TAZ
por: Kofler, Michael, et al.
Publicado: (2023)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
por: Merritt, Nicole, et al.
Publicado: (2021)

Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021)

Differential gene expression induced by Verteporfin in endometrial cancer cells
por: Bang, Lisa Gahyun, et al.
Publicado: (2019)

TAZ and YAP are frequently activated oncoproteins in sarcomas
por: Fullenkamp, Colleen A., et al.
Publicado: (2016)

YAP and TAZ are dispensable for physiological and malignant haematopoiesis
por: Donato, Elisa, et al.
Publicado: (2018)

The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
por: Azad, Taha, et al.
Publicado: (2019)

YAP and TAZ in Lung Development: The Timing Is Important
por: Warburton, David
Publicado: (2020)

Emerging Principles in the Transcriptional Control by YAP and TAZ
por: Lopez-Hernandez, Alejandro, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

YAP/TAZ: Molecular pathway and disease therapy
por: Wei, Yuzi, et al.
Publicado: (2023)

Inhibition of AKT with the Orally Active Allosteric AKT Inhibitor, MK-2206, Sensitizes Endometrial Cancer Cells to Progestin
por: Pant, Alok, et al.
Publicado: (2012)

How Phosphofructokinase-1 Promotes PI3K and YAP/TAZ in Cancer: Therapeutic Perspectives
por: Simula, Luca, et al.
Publicado: (2022)

The role of mechano-regulated YAP/TAZ in erectile dysfunction
por: Ji, Mintao, et al.
Publicado: (2023)

HIF-1α Regulates the Progression of Cervical Cancer by Targeting YAP/TAZ
por: Abudoukerimu, Azierguli, et al.
Publicado: (2022)

FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt
por: Dong, Jing, et al.
Publicado: (2017)

Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway
por: Dong, Liang, et al.
Publicado: (2018)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

YAP/TAZ initiate and maintain Schwann cell myelination
por: Grove, Matthew, et al.
Publicado: (2017)

The role of YAP/TAZ activity in cancer metabolic reprogramming
por: Zhang, Xiaodong, et al.
Publicado: (2018)

Relationship between Keloid Formation and YAP/TAZ Signaling
por: Aramaki-Hattori, Noriko, et al.
Publicado: (2017)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

Effect of YAP/TAZ on megakaryocyte differentiation and platelet production
por: Lorthongpanich, Chanchao, et al.
Publicado: (2020)

The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis
por: Kovar, Heinrich, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7lb8cd8en9majt6uck8db0vk0d